Hospital
Englewood Community Hospital, INC.
Englewood Community Hospital, INC. was paid $902K by Medicaid between Jan 2018 and Nov 2024, across 57 billing codes. Its largest line is 99283, emergency room visit (moderate) — 40% of everything it billed.
33Billing provider infoENGLEWOOD COMMUNITY HOSPITAL, INC.
ENGLEWOOD, FL 34223
ENGLEWOOD, FL 34223
33aNPI1639122864assigned 05/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$902K
24GClaims47,198
24DCodes billed57
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#131 of 163
Median peer was paid$4.77M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,317 | $24K | |
| 2019 | 11,682 | $140K | |
| 2020 | 9,065 | $96K | |
| 2021 | 11,094 | $241K | |
| 2022 | 7,918 | $232K | |
| 2023 | 3,409 | $124K | |
| 2024incomplete | 713 | $45K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 40% | 5,384 | 4,801 | $360K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 4,584 | 3,703 | $185K |
| 80053 | Comprehensive metabolic panel | 11% | 4,412 | 3,463 | $95K |
| 70450 | Computed tomography, head or brain; without contrast material | 6.8% | 919 | 694 | $61K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.9% | 592 | 566 | $44K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.5% | 494 | 376 | $23K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 105 | 96 | $20K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.7% | 138 | 130 | $15K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.7% | 281 | 237 | $15K |
| 87400 | 1.4% | 739 | 677 | $13K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 331 | 300 | $7K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,047 | 1,638 | $7K |
45 more codes
| 81003 | <1% | 810 | $6K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 12 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 755 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 219 | $5K |
| 81001 | <1% | 1,451 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 362 | $4K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,493 | $3K |
| 85027 | <1% | 5,122 | $3K | |
| 84484 | <1% | 1,827 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,325 | $3K |
| 85610 | <1% | 1,446 | $2K | |
| 83690 | <1% | 1,212 | $1K | |
| 81025 | <1% | 510 | $1K | |
| A9270 | Non-covered item or service | <1% | 1,274 | $1K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 78 | $1K |
| 85730 | <1% | 910 | $1K | |
| 83735 | <1% | 676 | $885.56 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 264 | $856.56 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,018 | $792.14 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 919 | $725.72 |
| 87040 | <1% | 200 | $491.34 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 91 | $465.35 |
| 87420 | <1% | 12 | $449.70 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 23 | $442.05 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,801 | $406.23 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 36 | $322.17 |
| 80061 | Lipid panel | <1% | 104 | $274.27 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 176 | $261.43 |
| 87077 | <1% | 55 | $134.22 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 30 | $50.36 |
| 82150 | <1% | 49 | $48.52 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 77 | $23.03 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 46 | $21.35 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 21 | $19.76 |
| 36415 | Collection of venous blood by venipuncture | <1% | 73 | $1.27 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 18 | $0.00 |
| 83605 | 0% | 226 | $0.00 | |
| 83880 | 0% | 224 | $0.00 | |
| 84703 | 0% | 12 | $0.00 | |
| 96376 | 0% | 34 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 24 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 13 | $0.00 |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 16 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 73 | $0.00 |
| 87186 | 0% | 55 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLINDSAY, KELLY (CEO)